- 全部删除
- 您的购物车当前为空
EGFR-IN-151 (Compound 10) 抑制EGFR和其下游信号通路ERK/STAT3。EGFR-IN-151 阻止多种肺癌细胞的增殖,其IC50对NCI-H1781、HCC827、NCI-H3255和NCI-H1975分别为11.7、5.19、7.32和1.53 μM,能抑制H1975的集落形成和细胞迁移,在G1期阻断细胞周期,并诱导H1975细胞凋亡(apoptosis)。
EGFR-IN-151 (Compound 10) 抑制EGFR和其下游信号通路ERK/STAT3。EGFR-IN-151 阻止多种肺癌细胞的增殖,其IC50对NCI-H1781、HCC827、NCI-H3255和NCI-H1975分别为11.7、5.19、7.32和1.53 μM,能抑制H1975的集落形成和细胞迁移,在G1期阻断细胞周期,并诱导H1975细胞凋亡(apoptosis)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
产品描述 | EGFR-IN-151 (Compound 10) inhibits EGFR and its downstream signaling pathways ERK/STAT3. It effectively suppresses the proliferation of various lung cancer cells, with IC50 values of 11.7, 5.19, 7.32, and 1.53 μM for NCI-H1781, HCC827, NCI-H3255, and NCI-H1975, respectively. Additionally, EGFR-IN-151 hinders colony formation and cell migration in H1975, induces G1 phase cell cycle arrest, and triggers apoptosis in H1975 cells. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容